Beamtree Holdings (ASX:BMT) Research & Development: A$0.00 Mil (TTM As of Dec. 2025)


ASX:BMT Beamtree Holdings Ltd ASX:BMT
28 GF Score
Price A$0.16
GF Value A$0.54
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Beamtree Holdings Research & Development?

Beamtree Holdings ASX:BMT +10.71% 28 Research & Development is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:BMT with a GF Score™ of 28/100 and a GF Value™ of A$0.54 (Possible Value Trap). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Beamtree Holdings's Research & Development for the six months ended in Dec. 2025 was A$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00 Mil.

Beamtree Holdings  (ASX:BMT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Beamtree Holdings Research & Development Related Terms

Beamtree Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Beamtree Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beamtree Holdings Research & Development Chart

Beamtree Holdings Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Beamtree Holdings Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:BMT
28GF Score
Beamtree Holdings Ltd ASX:BMT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beamtree Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of A$0.00 Mil mean?
Beamtree Holdings (ASX:BMT) has a Research & Development of A$0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Beamtree Holdings and its competitors.
Is Beamtree Holdings' Research & Development too high?
Beamtree Holdings' current Research & Development is A$0.00 Mil. Overall, Beamtree Holdings has a GF Score™ of 28/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Beamtree Holdings' Research & Development compare to VEEV and BTSG?
Beamtree Holdings' Research & Development of A$0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Beamtree Holdings and its competitors. Beamtree Holdings's current Research & Development is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beamtree Holdings stock overvalued right now?
Based on GuruFocus' analysis, Beamtree Holdings (ASX:BMT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.54, compared to a current price of A$0.16 — trading 71.3% below its estimated fair value. The current Research & Development is A$0.00 Mil. Beamtree Holdings' overall GF Score™ is 28/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Beamtree Holdings (ASX:BMT), the current Research & Development is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beamtree Holdings (ASX:BMT) Overvalued in 2026?

Based on GuruFocus' analysis, Beamtree Holdings stock appears to be undervalued. The current stock price of A$0.16 is trading 71.3% below its estimated GF Value™ of A$0.54. GuruFocus considers Beamtree Holdings to be Possible Value Trap.

Key valuation signals for ASX:BMT:

  • Research & Development: A$0.00 Mil
  • GF Value™: A$0.54 vs. price of A$0.16 (71.3% below fair value)
  • GF Score™: 28/100 with 4 warning signs

No single metric tells the full story. See the ASX:BMT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beamtree Holdings Business Description

Address 5 Blue Street, Suite 2, Level 10, North Sydney, Sydney, NSW, AUS, 2060
Beamtree Holdings Ltd is an Artificial intelligence (AI) health technology company. It offers software solutions like Picq, RippleDown, Risq, Ainsoff, Q Coding platform, and others across four product segments that combine into a modular software suite to assist healthcare services in transforming the quality of their data, analyzing key performance insights, and improving actionable decision support. The company's key operating product segments are: Knowledge Networks, which generate maximum revenue, Diagnostics, Clinical Decision Support, and Coding and Data Quality Assurance. Geographically, it operates in Australia, its key revenue-generating market, Europe, and the Rest of the world.
28GF Score

Get the complete analysis for ASX:BMT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.16
Price
A$0.54
GF Value